News
- 2026/01/05 InnoPharmax Submits Phase II Trial Application for D07001 (GemOral) to TFDA.
- 2026/01/02 InnoPharmax BendaReady Approved as New Bendamustine Formulation in Taiwan.
- 2025/12/09 Sapropterin Dihydrochloride Tablets Added to China’s Commercial Insurance Drug List.
- 2025/07/14 InnoPharmax-Licensed Gadopentetate Injection Wins 26-Province VBP Bid in China.
- 2025/07/09 InnoPharmax Partners with U.S. CRO for Global Phase III Trial of D07001-Softgel.
Vision and Strategy
Technologies
R&D
